Free Trial

HighTower Advisors LLC Raises Stock Holdings in Crocs, Inc. (NASDAQ:CROX)

Crocs logo with Consumer Discretionary background

HighTower Advisors LLC grew its position in Crocs, Inc. (NASDAQ:CROX - Free Report) by 122.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,307 shares of the textile maker's stock after purchasing an additional 9,539 shares during the quarter. HighTower Advisors LLC's holdings in Crocs were worth $2,507,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Financial Management Professionals Inc. lifted its position in shares of Crocs by 11,200.0% during the 3rd quarter. Financial Management Professionals Inc. now owns 226 shares of the textile maker's stock worth $33,000 after buying an additional 224 shares during the last quarter. GHP Investment Advisors Inc. raised its stake in Crocs by 375.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 228 shares of the textile maker's stock worth $33,000 after acquiring an additional 180 shares in the last quarter. UMB Bank n.a. lifted its position in Crocs by 64.9% in the third quarter. UMB Bank n.a. now owns 305 shares of the textile maker's stock valued at $44,000 after acquiring an additional 120 shares during the last quarter. V Square Quantitative Management LLC boosted its stake in Crocs by 83.0% in the third quarter. V Square Quantitative Management LLC now owns 313 shares of the textile maker's stock valued at $45,000 after acquiring an additional 142 shares in the last quarter. Finally, Avior Wealth Management LLC grew its holdings in shares of Crocs by 109.5% during the third quarter. Avior Wealth Management LLC now owns 398 shares of the textile maker's stock worth $58,000 after purchasing an additional 208 shares during the last quarter. 93.44% of the stock is owned by hedge funds and other institutional investors.

Crocs Price Performance

Shares of CROX traded down $1.22 during mid-day trading on Friday, hitting $111.72. The company's stock had a trading volume of 1,095,839 shares, compared to its average volume of 1,348,372. The firm has a 50-day simple moving average of $115.56 and a 200 day simple moving average of $132.16. Crocs, Inc. has a 1-year low of $85.71 and a 1-year high of $165.32. The firm has a market capitalization of $6.51 billion, a P/E ratio of 8.10, a P/E/G ratio of 1.14 and a beta of 1.98. The company has a current ratio of 1.43, a quick ratio of 0.90 and a debt-to-equity ratio of 0.82.

Crocs (NASDAQ:CROX - Get Free Report) last issued its earnings results on Tuesday, October 29th. The textile maker reported $3.60 EPS for the quarter, topping the consensus estimate of $3.10 by $0.50. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. Crocs had a net margin of 20.50% and a return on equity of 49.70%. The business's revenue was up 1.6% on a year-over-year basis. During the same period in the previous year, the firm earned $3.25 EPS. Analysts predict that Crocs, Inc. will post 12.93 EPS for the current fiscal year.

Insider Buying and Selling at Crocs

In other Crocs news, Director John B. Replogle acquired 2,240 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were purchased at an average cost of $112.60 per share, with a total value of $252,224.00. Following the purchase, the director now owns 9,304 shares in the company, valued at approximately $1,047,630.40. The trade was a 31.71 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Susan L. Healy bought 1,000 shares of the company's stock in a transaction on Wednesday, November 13th. The shares were acquired at an average price of $99.70 per share, with a total value of $99,700.00. Following the completion of the acquisition, the chief financial officer now directly owns 22,652 shares in the company, valued at $2,258,404.40. This represents a 4.62 % increase in their position. The disclosure for this purchase can be found here. 2.72% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CROX shares. Needham & Company LLC began coverage on Crocs in a report on Friday, November 22nd. They issued a "buy" rating and a $116.00 target price for the company. UBS Group decreased their price objective on Crocs from $146.00 to $122.00 and set a "neutral" rating for the company in a report on Wednesday, October 30th. Loop Capital lowered shares of Crocs from a "buy" rating to a "hold" rating and lowered their target price for the stock from $150.00 to $110.00 in a research report on Thursday, November 7th. Williams Trading upgraded shares of Crocs from a "hold" rating to a "buy" rating and upped their price target for the company from $135.00 to $163.00 in a research report on Thursday, August 22nd. Finally, Barclays lowered their price objective on shares of Crocs from $164.00 to $125.00 and set an "overweight" rating on the stock in a research report on Tuesday, October 29th. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $148.80.

Read Our Latest Stock Analysis on CROX

Crocs Company Profile

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Further Reading

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Should you invest $1,000 in Crocs right now?

Before you consider Crocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.

While Crocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group (UNH) is a powerhouse in healthcare, offering an impressive 14.7% average annual dividend increase over the last three years.

Related Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines